Both medications are given as weekly subcutaneous (under the skin) injections
Off-drug weight regain was observed and was accompanied by worsening glycemia and increase in progression to type 2 diabetes. Three-year safety of tirzepatide for weight loss Sean Wharton Sean Wharton, MD, FRCPC, PharmD , medical director of the Wharton Medical Clinic, adjunct professor at McMaster University in Hamilton, Ontario, and York University in Toronto, academic staff at Womens College Hospital and clinical staff at Hamilton Health Sciences, presented the main safety results of the 3-year trial
You might feel short-term soreness as your body adjusts to metabolic changes
Characterization of oxidative and antioxidative events during dehydration and rehydration of resurrection plant Ramonda nathaliae
for long-term storage, 20 C (4 F) is acceptable [9]
If you want to explore this, talk to your GP and ask them to refer you to an endocrinologist or obesity medicine specialist who is connected to trial networks